Skip to content
DraconiticResearch
Search Sources API
201,818 studies31 sourcesUpdated 44 min ago
Peer-reviewedCC BY 4.0Frontiers in Microbiology

SLA1 governs azole resistance in Candidozyma auris via mitochondrial ROS-driven efflux pump expression

  • Chenhao Suo1
  • Wanli Zhang2
  • Yuhan Li3
  • Chao Li4
  • Yaning Cui5
  • Yuwei Xiao1
  • Jianjun Lei1
  • Yiru Gao6
  • He Zhang1
6 affiliations
  1. 1Department of Laboratory Animal Center, General Hospital of Northern Theater Command
  2. 2The State Key Laboratory of Pharmaceutical Biotechnology, Chemistry and Biomedicine Innovation Center (ChemBIC), Division of Immunology, Medical School, Nanjing University
  3. 3College of Animal Science and Veterinary Medicine, Shenyang Agricultural University
  4. 4Department of Emergency Medicine, The Second Affiliated Hospital of Army Medical University
  5. 5State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Hospital of China Medical University
  6. 6College of Life and Health Science, Northeastern University
Read full textPDFDOICite

Abstract

Introduction: Candidozyma auris is an emerging multidrug-resistant fungal pathogen, and widespread fluconazole (FLC) resistance severely limits clinical treatment options. Overexpression of the efflux transporter CDR1 represents a major driver of azole resistance; however, how oxidative stress modulates this process remains poorly understood. This study aimed to identify novel regulators that connect oxidative stress adaptation with azole resistance in C. auris .

Methods: We constructed SLA1 deletion mutants of C. auris . SLA1 encodes a conserved regulator of cytoskeletal organization and membrane trafficking. We evaluated mitochondrial homeostasis, mtROS accumulation, and CDR1 expression. Pharmacological mitochondrial perturbation was used to disentangle the individual effects of ROS accumulation and mitochondrial dysfunction on FLC resistance. We further assessed cell envelope integrity, in vivo virulence, and the transcriptional correlation between SLA1 and CDR1 using clinical isolates.

Results: SLA1 deletion triggered mitochondrial dysfunction, increased mtROS accumulation, upregulated CDR1 , and enhanced azole resistance. Pharmacological disruption of mitochondria further raised ROS levels yet suppressed CDR1 , depleted ATP, accumulated NADH, and abolished FLC resistance. This indicates that ROS elevation alone cannot sustain resistance under severe mitochondrial impairment. SLA1 knockout compromised cell envelope integrity and attenuated in vivo virulence, revealing a fitness trade-off during antifungal adaptation. Clinical isolates exhibited a significant inverse correlation between SLA1 and CDR1 transcript levels.

Discussion: This study identifies SLA1 as a previously uncharacterized modulator of oxidative stress adaptation and azole susceptibility in C. auris . Mitochondrial functional status governs the relationship between oxidative stress and azole resistance. The SLA1 -dependent axis promotes antifungal resistance at the expense of reduced virulence. These findings reveal a new mechanism of drug adaptation in C. auris and point to a potential target for combating multidrug-resistant C. auris .

Related

  1. Whole-genome characterization of Candidozyma auris isolates from a Korean tertiary care centre: clade II predominance, partly unexplained fluconazole resistance and a clade I isolate
    Jae Hyeon Park, Jee-Soo Lee, Seung Won Chae +2
    Microbial GenomicsPeer-reviewedCC BY 4.0Full textInfectious diseasePMC
  2. ACAT1/SOAT1 governs mitochondrial dynamics and thermogenesis via the mTOR-MFN2-USP2 axis in brown adipocytes
    Wei Duan, Mengyao Wang, Yaming Yuan +14
    Nature CommunicationsPeer-reviewedCC BY-NC-ND 4.0Full textPhysiologyCrossref
  3. Generic context-dependence governs clonal emergence of ciprofloxacin resistance mutations
    Anamika Ghosh, Protyusa Deb, Puja Bose +5
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textGeneral medicineCrossref
  4. Diurnal regulation of Acyl-CoA synthetase 3 (ACSF3) governs rhythmic mitochondrial lysine-malonylation and daily hepatic metabolism
    Enora Le Questel, Charlène Besnard, Florian Atger +14
    Cell ReportsPeer-reviewedCC BY 4.0Full textPhysiologyHAL
  5. Identification of Mitochondrial Dynamics-Related Genes as Diagnostic Biomarkers for Osteoarthritis Using Weighted Gene Co-expression Network Analysis and Machine Learning
    Hui Wang, Peng Zhang, Xinqiang Ren +3
    Clinics in orthopedic surgeryPeer-reviewedCC BY-NCFull textSurgery & anaesthesiaEurope PMC

Cite

BibTeXRIS
BibTeX
@article{suo2026sla1,
  title = {{SLA1 governs azole resistance in Candidozyma auris via mitochondrial ROS-driven efflux pump expression}},
  author = {Chenhao Suo and Wanli Zhang and Yuhan Li and Chao Li and Yaning Cui and Yuwei Xiao and Jianjun Lei and Yiru Gao and He Zhang},
  journal = {Frontiers in Microbiology},
  year = {2026},
  month = oct,
  doi = {10.3389/fmicb.2026.1948008},
  url = {https://www.frontiersin.org/articles/10.3389/fmicb.2026.1948008/full},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - SLA1 governs azole resistance in Candidozyma auris via mitochondrial ROS-driven efflux pump expression
AU  - Chenhao Suo
AU  - Wanli Zhang
AU  - Yuhan Li
AU  - Chao Li
AU  - Yaning Cui
AU  - Yuwei Xiao
AU  - Jianjun Lei
AU  - Yiru Gao
AU  - He Zhang
PY  - 2026
DA  - 2026/10/07
JO  - Frontiers in Microbiology
DO  - 10.3389/fmicb.2026.1948008
UR  - https://www.frontiersin.org/articles/10.3389/fmicb.2026.1948008/full
AB  - Introduction: Candidozyma auris is an emerging multidrug-resistant fungal pathogen, and widespread fluconazole (FLC) resistance severely limits clinical treatment options. Overexpression of the efflux transporter CDR1 represents a major driver of azole resistance; however, how oxidative stress modulates this process remains poorly understood. This study aimed to identify novel regulators that connect oxidative stress adaptation with azole resistance in C. auris .  Methods: We constructed SLA1 deletion mutants of C. auris . SLA1 encodes a conserved regulator of cytoskeletal organization and membrane trafficking. We evaluated mitochondrial homeostasis, mtROS accumulation, and CDR1 expression. Pharmacological mitochondrial perturbation was used to disentangle the individual effects of ROS accumulation and mitochondrial dysfunction on FLC resistance. We further assessed cell envelope integrity, in vivo virulence, and the transcriptional correlation between SLA1 and CDR1 using clinical isolates.  Results: SLA1 deletion triggered mitochondrial dysfunction, increased mtROS accumulation, upregulated CDR1 , and enhanced azole resistance. Pharmacological disruption of mitochondria further raised ROS levels yet suppressed CDR1 , depleted ATP, accumulated NADH, and abolished FLC resistance. This indicates that ROS elevation alone cannot sustain resistance under severe mitochondrial impairment. SLA1 knockout compromised cell envelope integrity and attenuated in vivo virulence, revealing a fitness trade-off during antifungal adaptation. Clinical isolates exhibited a significant inverse correlation between SLA1 and CDR1 transcript levels.  Discussion: This study identifies SLA1 as a previously uncharacterized modulator of oxidative stress adaptation and azole susceptibility in C. auris . Mitochondrial functional status governs the relationship between oxidative stress and azole resistance. The SLA1 -dependent axis promotes antifungal resistance at the expense of reduced virulence. These findings reveal a new mechanism of drug adaptation in C. auris and point to a potential target for combating multidrug-resistant C. auris .
SN  - 1664-302X
ER  -